Share

Search your stocks

Ctrl+K

INFINIUMInfinium Pharmachem Ltd.

251(-2.14%)

1W: +3.01%

1M: -3.93%

1Y: +16.59%

Infinium Pharmachem Quarterly Results

Pros & Cons

POSITIVES

Consistent revenue growth over the last three quarters indicates strong demand for products.
Improved profit margins suggest better cost management and operational efficiency.
Increased R&D expenditure could lead to innovative product offerings, enhancing competitive edge.

NEGATIVES

Declining net profit in the latest quarter raises concerns about sustainability.
Increasing raw material costs may pressure margins in future quarters.
Rising debt levels could limit financial flexibility and increase risk exposure.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-